Article

AJMC® in the Press, August 27, 2021

Author(s):

Matthew Gavidia

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article by Wyoming News Now referenced an article published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The article, “A Timeline of COVID-19 Developments in 2020,” provides an overview of how the COVID-19 pandemic evolved and progressed last year.

A piece by VeryWellHealth featured an interview with Anthony Hagen, senior editor of AJMC®’s sister site The Center for Biosimilars®. In the piece, Hagen discussed how in the absence of biosimilar competition, originator companies are in some cases able to raise their drug prices to exorbitant levels.

Related Videos
Benjamin Scirica, MD, MPH, associate professor of medicine at Harvard Medical School and director of quality initiatives at Brigham and Women’s Hospital’s Cardiovascular Division
Laurence Sperling, MD
Tiara Green MSEd
Tiara Green MSEd
Michael Morse, MD, Duke Cancer Center
Screenshot of Ryan Nix, PharmD, during a video interview
Leslie Fish, PharmD.
Mila Felder, MD, FACEP
Shawn Gremminger
Dr Lucy Langer
Related Content
Lindsay Bealor Greenleaf, JD, MBA | Image credit: ADVI Health
November 12th 2024

The Trump Sequel: What to Expect on PBMs, 340B, Drug Pricing, and RFK Jr

Interview by Mary Caffrey
Lindsay Bealor Greenleaf, JD, MBA, of ADVI Health, weighs in on what to expect in key health care policy areas in the wake of the election.
Managed Care Cast
November 21st 2024

Frameworks for Advancing Health Equity: Wellness Way

Giuliana Grossi
The Wellness Way facility was designed to improve access to comprehensive outpatient care and address social determinants of health for a diverse patient population.
MPN Congress logo | Image Credit: 16th International Congress on Myeloproliferative Neoplasms
November 9th 2024

Lower Pharmacy Costs Give Ruxolitinib Edge for Patients With MF and Anemia

Mary Caffrey
Authors found the pharmacy costs for momelotinib were $11,095 higher per month, too much to offset higher transfusion costs for ruxolitinib.
Managed Care Cast logo
May 7th 2024

CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection

Brooke McCormick
On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
AJMC
November 5th 2024

Privately Negotiated Facility Fees at Ambulatory Surgery Centers and Hospitals

Daphne T. Hao Vinay K. Rathi, MD, MBA Joseph S. Ross, MD, MHS Rosh K. V. Sethi, MD, MPH Roy Xiao, MD, MS
Private negotiated facility fees at hospitals are on average double the ambulatory surgery center facility fees for common outpatient procedures.
Before transfusion dose blood inside hospital room - sudok1 - stock.adobe.com
October 30th 2024

High Health Care Burden of Transfusion-Dependent β-Thalassemia

Giuliana Grossi
Patients with transfusion-dependent β-thalassemia experienced 14.8 hospitalizations annually, according to the findings.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo